Prostate Cancer Therapy Linked to Cataract Development

Patients receiving androgen deprivation therapy (ADT) to treat prostate cancer may be at a higher risk of developing cataracts, according to a study in the Annals of Epidemiology.1 Side effects associated with ADT (such as weight gain, dyslipidemia, and insulin resistance) have been linked to cataract, according to res...